SSRIs and Ketamine: Discussing Side Effects and Treatment Changes

Important: Compounded ketamine is not FDA-approved. FDA has not evaluated its safety, effectiveness, or quality before marketing. Ketamine injection is approved for anesthesia, not psychiatric conditions. Compounded ketamine nasal spray is different from FDA-approved Spravato (esketamine), and research on other formulations or treatment settings does not establish its benefits.

Side effects can be a major reason someone looks for another depression treatment. They deserve a direct conversation, including sensitive concerns such as sexual function. A comparison should acknowledge each option’s risks without promising that a different medication solves every problem.

Describe the concern clearly

SSRIs, including medications such as fluoxetine, are used for depression and certain other conditions. The NIMH medication overview notes that antidepressants can cause effects such as gastrointestinal symptoms, headache, or sexual dysfunction. Individual experiences vary.

Tell your clinician when a change began, how often it occurs, whether it followed a dose adjustment, and how it affects daily life. Include benefits you have noticed as well. This creates a more useful picture than simply describing a medication as good or bad.

Avoid unsupported assurances about ketamine

A claim that ketamine never affects libido, never causes emotional blunting, or always has fewer side effects is not a reliable basis for treatment. Different mechanisms do not guarantee a better personal experience. Compounded nasal medication also has not undergone FDA premarket review.

Immediate effects and longer-term concerns should both be discussed. Sedation or dissociation may affect what you can do around treatment, while repeated-use concerns require follow-up. Feeling a dose is gentle does not prove that it is medically low-risk.

Coordinate any change

Ask whether adjusting your current treatment, trying another approved medication, or adding psychotherapy could address the problem. If another approach is considered, ask who will supervise the transition and how withdrawal symptoms or returning depression will be managed.

The MedlinePlus fluoxetine resource advises patients not to stop that medication without discussing it with their clinician. Instructions vary by medication; follow the guidance for your own prescription rather than another person’s experience.

Set expectations before deciding

• Which side effect are we trying to address?
• What alternatives have evidence relevant to me?
• How soon will we review benefit and unwanted effects?
• Who should I contact if symptoms become worse?

An honest comparison includes uncertainty and leaves room to choose a different plan after further assessment.

Safety and the treatment setting

Ketamine can cause sedation, dissociation, impaired thinking or coordination, nausea, increased blood pressure or heart rate, and slowed breathing. Abuse or misuse, worsening psychiatric symptoms, and urinary or bladder problems are also concerns. This is not a complete list of risks.

At home, a healthcare professional is not onsite to monitor you or respond immediately to an adverse reaction. Telehealth support does not provide the same monitoring as an onsite care team. Review these FDA ketamine risk alerts and discuss your health history, other medications, monitoring needs, and emergency plan with your clinician.

Discuss your options

Bliss Mist Rx LLC provides telehealth services; we do not manufacture or compound medication. If a clinician prescribes treatment, an independent, appropriately licensed compounding pharmacy dispenses it. A consultation does not guarantee a prescription or a particular outcome. Book a Free Virtual Appointment or Follow-Up to discuss questions about your care.

This article is general education and does not replace individualized medical advice.